1. Early and long-term outcomes of argatroban use in patients with acute noncardioembolic stroke
   Shumin Chen et al, 2020, Clinical Neurology and Neurosurgery CrossRef
2. An Overview of Thrombin Inhibitors in the Perspective of Structureactivity Relationships
   Jiangming Wang et al, 2023, Current Medicinal Chemistry CrossRef
3. The Crosstalk between Nephropathy and Coagulation Disorder: Pathogenesis, Treatment, and Dilemmas
   Zhiwei Qiu et al, 2023, Journal of the American Society of Nephrology CrossRef
4. RGD-hirudin-based low molecular weight peptide prevents blood coagulation via subcutaneous injection
   Ya-ran Li et al, 2020, Acta Pharmacologica Sinica CrossRef
5. Alpha gal syndrome, a relative not absolute contraindication to the use of bovine pericardium to close an intracardiac septal defect: a case report
   Kimi Taira et al, 2024, Journal of Cardiothoracic Surgery CrossRef
6. Computer Design of Low-Molecular-Weight Inhibitors of Coagulation Factors
   A. S. Kabankin et al, 2019, Biochemistry (Moscow) CrossRef
7. Drug delivery systems for cardiovascular ailments
   Sharadwata Pan et al, 2021, Drug Delivery Devices and Therapeutic Systems CrossRef
8. Venom peptides – A comprehensive translational perspective in pain management
   Vidya V et al, 2021, Current Research in Toxicology CrossRef
9. Investigation of Interactions between Thrombin and Ten Phenolic Compounds by Affinity Capillary Electrophoresis and Molecular Docking
   Qiao-Qiao Li et al, 2018, Journal of Analytical Methods in Chemistry CrossRef
10. Exploiting the antithrombotic effect of the (pro)thrombin inhibitor bothrojaracin
    Mariane Assafim et al, 2016, Toxicon CrossRef
11. New Frontiers in Druggability
    Dima Kozakov et al, 2015, Journal of Medicinal Chemistry CrossRef
12. Discovery of novel N-acylpyrazoles as potent and selective thrombin inhibitors
    Kevin M. Short et al, 2023, European Journal of Medicinal Chemistry CrossRef
13. Why to Study Peptides from Venomous and Poisonous Animals?
    Ana Novo de Oliveira et al, 2023, International Journal of Peptide Research and Therapeutics CrossRef
14. Complement System Inhibition Modulates the Pro-Inflammatory Effects of a Snake Venom Metalloproteinase
    Lygia Samartin Gonçalves Luchini et al, 2019, Frontiers in Immunology CrossRef
15. Design, synthesis and biological activity evaluation of novel methyl substituted benzimidazole derivatives
    Tianrong Zhang et al, 2020, Tetrahedron CrossRef
16. Microfluidic Point-of-Care Ecarin-Based Clotting and Chromogenic Assays for Monitoring Direct Thrombin Inhibitors
    Benjamin Alouidor et al, 2019, The Journal of ExtraCorporeal Technology CrossRef
17. Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke
    Hiroaki Oguro et al, 2018, Journal of Stroke and Cerebrovascular Diseases CrossRef
18. Targeting eukaryotic proteases for natural products-based drug development
    Fatma H. Al-Awadhi et al, 2020, Natural Product Reports CrossRef
19. Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis
    Vishnu Priya et al, 2021, Nanomedicine CrossRef